Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase
2011

Cross-linking of Plasmodium falciparum Liver Stage Antigen-1 by Tissue Transglutaminase

publication Evidence: moderate

Author Information

Author(s): William S. Nicoll, John B. Sacci, Carlo Rodolfo, Giuseppina Di Giacomo, Mauro Piacentini, Zoe J. M. Holland, Christian Doerig, Michael R. Hollingdale, David E. Lanar

Primary Institution: U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research

Hypothesis

Does tissue transglutaminase cross-link Liver Stage Antigen-1 in Plasmodium falciparum?

Conclusion

The study suggests that LSA-1 becomes highly cross-linked, which may help protect the parasite during its development.

Supporting Evidence

  • LSA-1 is a protein produced by malaria parasites during their development in the liver.
  • Tissue transglutaminase can modify proteins by forming unique cross-links.
  • The study demonstrated that LSA-1 is cross-linked in infected human hepatocytes.

Takeaway

This study found that a protein from malaria parasites sticks together in a special way, which might help the parasites survive in the liver.

Methodology

The study used recombinant proteins and in vitro assays to test for cross-linking by tissue transglutaminase.

Limitations

The study could not purify native LSA-1 due to low infection rates in the chimeric mouse model.

Digital Object Identifier (DOI)

10.1186/1475-2875-10-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication